Opportunity Information: Apply for RFA HD 10 013
Apply for RFA HD 10 013
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (STTR R41)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.838 Lung Diseases Research 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Jul 16, 2010 and posted on Jul 16, 2010.
- Applicants must submit their applications by Sep 17, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $450,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (STTR R41)" is a National Institutes of Health (NIH) Funding Opportunity Announcement aimed at helping small businesses create better technology for caring for newborns and very young children in neonatal intensive care units (NICUs). The central goal is to support early-stage research and development that leads to safer, more effective instruments and devices used to monitor and treat fragile infants and small children. In practical terms, the FOA is looking for projects that either invent entirely new NICU-relevant devices or substantially improve existing ones, with a clear emphasis on safety, clinical usefulness, and effectiveness in real neonatal care settings.
This program uses the Small Business Technology Transfer (STTR) mechanism, specifically the R41 Phase I award. That matters because STTR is designed around a formal collaboration between a U.S. small business concern and a nonprofit research institution (such as a university or hospital). Phase I typically focuses on demonstrating feasibility: proving the core concept works, establishing early performance data, building prototypes or benchtop versions where appropriate, and identifying technical or clinical risks that must be resolved before larger development efforts. The announcement also notes that it runs in parallel with a companion solicitation of the same scientific scope under the Small Business Innovative Research (SBIR) program (R43), which is a closely related small-business R&D pathway but with different collaboration and effort requirements. Importantly, this specific STTR FOA does not support Phase II, Fast Track, or Phase II Competing Renewal applications, meaning it is limited to Phase I proposals only and applicants would need to look to other mechanisms or future opportunities for later-stage expansion funding.
Eligibility is limited to small businesses, and the funding does not require cost sharing or matching. For fiscal year 2011, two NIH institutes are highlighted as setting aside funds: the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung, and Blood Institute (NHLBI). Each institute set aside $450,000, with an expectation of funding up to two meritorious applications per institute, depending on application quality and program priorities. The award ceiling listed is $225,000, which effectively signals the maximum budget size NIH expected for an individual Phase I award under this FOA. The total number of awards and final amounts could vary, and the announcement makes clear that future-year funding would depend on congressional appropriations.
From an administrative standpoint, the opportunity is categorized as a discretionary grant in the health domain, and it is associated with CFDA numbers 93.838 (Lung Diseases Research) and 93.865 (Child Health and Human Development Extramural Research. The FOA was posted on July 16, 2010, with an application deadline of September 17, 2010, and an archive date of October 18, 2010, indicating it was a time-limited call. The provided contact information is primarily technical or access-related, directing applicants to the NIH Office of Extramural Research (OER) webmaster for difficulties accessing the full announcement or resolving linking issues. The full FOA text was made available through the NIH grants guide website, which typically includes the detailed requirements for STTR partnerships, required application sections, budget rules, review criteria, and any NICU-focused scientific priorities that applicants would need to address in a competitive submission.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The funding opportunity is titled "Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (STTR R41)."
Who is offering this funding opportunity?
This is a National Institutes of Health (NIH) Funding Opportunity Announcement (FOA).
What is the main purpose of this FOA?
The central purpose is to support early-stage research and development by small businesses to create safer and more effective instruments and devices for monitoring and treating newborns and very young children in neonatal intensive care units (NICUs).
What kinds of projects does the FOA want to support?
The FOA is interested in projects that either (1) invent entirely new NICU-relevant instruments/devices or (2) substantially improve existing NICU instruments/devices, with a clear emphasis on safety, clinical usefulness, and effectiveness in real neonatal care settings.
What award mechanism is used for this opportunity?
This FOA uses the Small Business Technology Transfer (STTR) mechanism, specifically the R41 Phase I award.
What does "STTR" imply for applicants?
STTR is designed around a formal collaboration between a U.S. small business concern and a nonprofit research institution (for example, a university or hospital). Applicants should expect the FOA to require this type of partnership structure.
What is the focus of a Phase I (R41) award under this FOA?
Phase I is generally focused on feasibility. Based on the FOA description, this can include demonstrating that the core concept works, generating early performance data, developing prototypes or benchtop versions where appropriate, and identifying technical or clinical risks that would need to be addressed before larger development efforts.
Does this FOA support Phase II funding?
No. This specific STTR FOA does not support Phase II, Fast Track, or Phase II Competing Renewal applications. It is limited to Phase I proposals only.
If Phase II is not supported here, what does that mean for later-stage development?
Because this FOA is Phase I only, applicants would need to look to other mechanisms or future opportunities for later-stage expansion funding beyond feasibility work.
Is there a related SBIR opportunity mentioned?
Yes. The announcement notes that it runs in parallel with a companion solicitation of the same scientific scope under the Small Business Innovative Research (SBIR) program (R43). SBIR is described as closely related to STTR but with different collaboration and effort requirements.
Who is eligible to apply?
Eligibility is limited to small businesses.
Is cost sharing or matching required?
No. The FOA states that the funding does not require cost sharing or matching.
Which NIH institutes are highlighted as participating in FY2011 set-aside funding?
Two NIH institutes are highlighted: the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung, and Blood Institute (NHLBI).
How much funding was set aside by NICHD and NHLBI for FY2011?
For fiscal year 2011, NICHD set aside $450,000 and NHLBI set aside $450,000 for this FOA.
How many awards were expected to be made?
Each of the two highlighted institutes expected to fund up to two meritorious applications, depending on application quality and program priorities. The actual number of awards could vary.
What is the maximum award amount (award ceiling) mentioned?
The award ceiling listed is $225,000, which indicates the maximum budget size NIH expected for an individual Phase I award under this FOA.
Can the final award amounts or number of awards change?
Yes. The FOA indicates that total awards and final amounts could vary, and it also notes that future-year funding depends on congressional appropriations.
What type of funding opportunity is this categorized as?
It is categorized as a discretionary grant in the health domain.
What CFDA numbers are associated with this FOA?
The FOA is associated with CFDA 93.838 (Lung Diseases Research) and CFDA 93.865 (Child Health and Human Development Extramural Research).
When was the FOA posted?
The FOA was posted on July 16, 2010.
What was the application deadline?
The application deadline was September 17, 2010.
What does the archive date indicate?
The archive date is October 18, 2010, which indicates this was a time-limited call and has been archived.
Where was the full FOA text made available?
The full FOA text was made available through the NIH grants guide website.
What kinds of details would typically be found in the full FOA text?
According to the description provided, the full FOA text typically includes detailed requirements for STTR partnerships, required application sections, budget rules, review criteria, and any NICU-focused scientific priorities that applicants would need to address in a competitive submission.
Who should be contacted if there are problems accessing the full announcement?
The provided contact information is primarily technical or access-related, directing applicants to the NIH Office of Extramural Research (OER) webmaster for difficulties accessing the full announcement or resolving linking issues.
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: Craig Ranch Regional Park Develoment SNPLMA continuation
Previous opportunity: Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (SBIR R43)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HD 10 013
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HD 10 013) also looked into and applied for these:
| Funding Opportunity |
|---|
| Innovative Therapies and Tools for Screenable Disorders in Newborns (R03) Apply for PAR 10 231 Funding Number: PAR 10 231 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Developmental Mechanisms of Human Structural Birth Defects (P01) Apply for RFA HD 10 006 Funding Number: RFA HD 10 006 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $900,000 |
| NICHD Program Project Grant (P01) Apply for PAR 10 245 Funding Number: PAR 10 245 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Molecular Mechanisms of Adverse Metabolic Drug Effects in Children and Adolescents (R01) Apply for RFA HD 10 010 Funding Number: RFA HD 10 010 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $250,000 |
| Dual Purpose with Dual Benefit Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Species (R01) Apply for PAR 10 276 Funding Number: PAR 10 276 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Identifying and Understanding Effective Interventions for Orphans and Vulnerable Children Affected by HIV/AIDS (R01) Apply for RFA HD 10 017 Funding Number: RFA HD 10 017 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01) Apply for PAR 11 038 Funding Number: PAR 11 038 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Understanding and Treating Co Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R01) Apply for PA 11 039 Funding Number: PA 11 039 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Understanding and Treating Co Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R03) Apply for PA 11 040 Funding Number: PA 11 040 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Understanding and Treating Co Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R21) Apply for PA 11 041 Funding Number: PA 11 041 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Specialized Cooperative Centers Program in Reproduction and Infertility Research (U54) Apply for RFA HD 12 169 Funding Number: RFA HD 12 169 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Outcome Measures for Use in Treatment Trials for Individuals with Intellectual and Developmental Disabilities (R01) Apply for PAR 11 045 Funding Number: PAR 11 045 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Indo US Collaborative Program on Low Cost Medical Devices (R03) Apply for PAR 11 044 Funding Number: PAR 11 044 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Mechanisms of Adverse Drug Reactions in Children (R01) Apply for PAR 11 051 Funding Number: PAR 11 051 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Mechanisms of Adverse Drug Reactions in Children (R03) Apply for PAR 11 052 Funding Number: PAR 11 052 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Studies in Neonatal Hypoglycemia (R03) Apply for PA 11 054 Funding Number: PA 11 054 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Studies in Neonatal Hypoglycemia (R01) Apply for PA 11 053 Funding Number: PA 11 053 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Studies in Neonatal Hypoglycemia (R21) Apply for PA 11 055 Funding Number: PA 11 055 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Mentored Patient Oriented Research Career Development Award in Muscular Dystrophy Research (K23) Apply for PA 11 076 Funding Number: PA 11 076 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| NIH Pathway to Independence Award in Muscular Dystrophy Research (K99/R00) Apply for PA 11 078 Funding Number: PA 11 078 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HD 10 013", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.